Search

everythinglearnresearchcommunity

for

Search:↓

JAK inhibitors show promise as a future treatment for hair loss.

Hair loss in a drug reaction case involved both a common shedding phase and an immune attack on hair follicle stem cells.

Tofacitinib improved arthritis and partially improved hair loss in a lupus patient without side effects.

An 87-year-old woman was diagnosed with type 3 autoimmune polyendocrine syndrome and had multiple autoimmune issues.

Lichen planopilaris is a chronic, scarring hair loss condition with no definitive cure, requiring accurate diagnosis and treatment to manage symptoms.

Combining diphenylcyclopropenone with anthralin is more effective for hair regrowth in alopecia areata than using diphenylcyclopropenone alone, but may cause more side effects.

People with alopecia areata often have higher rates of allergies and autoimmune diseases.

No link found between Coxsackie viruses and pemphigus.

Different hair loss types need accurate diagnosis for proper treatment.

A man with hypoparathyroidism had other health issues that led to a diagnosis of a rare autoimmune disorder, APS-1.

A patient with alopecia had hair regrowth with tofacitinib but developed a skin reaction, choosing to continue the treatment despite the side effect.

Lichen planopilaris can be accurately diagnosed and effectively treated.

M-CSF-stimulated myeloid cells can cause alopecia areata in mice.

PRP injections significantly improve hair regrowth in alopecia areata.

PRP may help hair growth in alopecia areata without major side effects, but more research is needed.

Differences in growth factors in platelet-rich plasma therapy for hair loss can vary between patients and can be influenced by the devices used, possibly leading to inconsistent results.

Some hair loss disorders cause permanent loss due to scarring, and treatments like steroids don't always work well.

Guidelines suggest various treatments for alopecia areata, but leaving it untreated is also an option as 80% cases may recover on their own.

Stress-related substance P may lead to hair loss and negatively affect hair growth.

Male and female skin differ due to hormones, affecting conditions like hair loss, acne, and skin cancer, and suggesting a need for gender-specific treatments.

Most people with systemic lupus erythematosus have skin problems, and skin symptoms are often the first sign of the disease.

Skin grafts on mice can cause an immune response leading to hair loss, useful for studying human hair loss conditions.

The document concludes that hair is complex, with a detailed growth cycle, structure, and clinical importance, affecting various scientific and medical fields.

Prolactin affects hair growth and skin conditions, and could be a target for new skin disease treatments.

Mice studies show that Protein Phosphatase 2A is crucial for cell growth, development, and disease prevention.

Alopecia areata can cause unpredictable hair loss, and treatments like corticosteroids and minoxidil may help but have varying side effects.

The FOXN1 gene is crucial for developing immune cells and preventing immune disorders.

Men are more likely to get infectious skin diseases, while women are more prone to autoimmune and pigment-related skin conditions, influenced by biological and environmental factors.

Scarring alopecias are complex hair loss disorders that require early treatment to prevent permanent hair loss.

Targeting CD200 could be a new treatment for rheumatoid arthritis.